249 related articles for article (PubMed ID: 8104650)
1. Alfuzosin, a selective alpha 1-adrenoceptor antagonist in the lower urinary tract.
Lefèvre-Borg F; O'Connor SE; Schoemaker H; Hicks PE; Lechaire J; Gautier E; Pierre F; Pimoule C; Manoury P; Langer SZ
Br J Pharmacol; 1993 Aug; 109(4):1282-9. PubMed ID: 8104650
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the pharmacological selectivity profile of alpha 1 adrenoceptor antagonists at prostatic alpha 1 adrenoceptors: binding, functional and in vivo studies.
Kenny BA; Miller AM; Williamson IJ; O'Connell J; Chalmers DH; Naylor AM
Br J Pharmacol; 1996 Jun; 118(4):871-8. PubMed ID: 8799556
[TBL] [Abstract][Full Text] [Related]
3. Effects of different alpha-1 adrenoceptor blockers on proximal urethral function using in vivo isovolumetric pressure changes.
Yamaguchi T; Nagano M; Osada Y
J Smooth Muscle Res; 2005 Oct; 41(5):247-56. PubMed ID: 16428864
[TBL] [Abstract][Full Text] [Related]
4. The pharmacology of RS-15385-197, a potent and selective alpha 2-adrenoceptor antagonist.
Brown CM; MacKinnon AC; Redfern WS; Hicks PE; Kilpatrick AT; Small C; Ramcharan M; Clague RU; Clark RD; MacFarlane CB
Br J Pharmacol; 1993 Feb; 108(2):516-25. PubMed ID: 8095420
[TBL] [Abstract][Full Text] [Related]
5. Effects of alpha1-adrenoceptor antagonists on agonist and tilt-induced changes in blood pressure: relationships to uroselectivity.
Hieble JP; Kolpak DC; McCafferty GP; Ruffolo RR; Testa R; Leonardi A
Eur J Pharmacol; 1999 May; 373(1):51-62. PubMed ID: 10408251
[TBL] [Abstract][Full Text] [Related]
6. Postjunctional alpha-adrenoceptors in the rabbit isolated distal saphenous artery: indirect sensitivity to prazosin of responses to noradrenaline mediated via postjunctional alpha 2-adrenoceptors.
Dunn WR; McGrath JC; Wilson VG
Br J Pharmacol; 1991 Jun; 103(2):1484-92. PubMed ID: 1679360
[TBL] [Abstract][Full Text] [Related]
7. Alfuzosin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in benign prostatic hyperplasia.
Wilde MI; Fitton A; McTavish D
Drugs; 1993 Mar; 45(3):410-29. PubMed ID: 7682910
[TBL] [Abstract][Full Text] [Related]
8. In vivo experiments for the evaluation of alpha 1-adrenoceptor antagonistic effects of SGB-1534 on canine urethra.
Imagawa J; Akima M; Sakai K
Eur J Pharmacol; 1989 Aug; 167(1):167-72. PubMed ID: 2570705
[TBL] [Abstract][Full Text] [Related]
9. Effect of JTH-601, a novel alpha1-adrenoceptor antagonist, on the function of lower urinary tract and blood pressure.
Suzuki Y; Kanada A; Okaya Y; Aisaka K; Muramatsu I
Eur J Pharmacol; 1999 Jun; 374(3):495-502. PubMed ID: 10422795
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological characterization of alpha 1-adrenoceptor subtype mediating regulation of arterial pressure and urethral perfusion pressure in the anaesthetized rat.
Guilmard C; Auguet M; Chabrier PE
J Auton Pharmacol; 1996 Aug; 16(4):197-203. PubMed ID: 8953374
[TBL] [Abstract][Full Text] [Related]
11. Evidence for two distinct types of postsynaptic alpha-adrenoceptor in vascular smooth muscle in vivo.
Drew GM; Whiting SB
Br J Pharmacol; 1979 Oct; 67(2):207-15. PubMed ID: 40647
[TBL] [Abstract][Full Text] [Related]
12. Relationship between the effects of alfuzosin on rat urethral and blood pressures and its tissue concentrations.
Martin DJ; Lluel P; Pouyet T; Rauch-Desanti C; Angel I
Life Sci; 1998; 63(3):169-76. PubMed ID: 9698046
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological activity of DC-015, a novel potent and selective alpha 1-adrenoceptor antagonist.
Yen MH; Sheu JR; Peng IH; Lee YM; Chern JW
J Pharm Pharmacol; 1996 Jan; 48(1):90-5. PubMed ID: 8722503
[TBL] [Abstract][Full Text] [Related]
14. Selective blockade by nicergoline of vascular responses elicited by stimulation of alpha 1A-adrenoceptor subtype in the rat.
Alvarez-Guerra M; Bertholom N; Garay RP
Fundam Clin Pharmacol; 1999; 13(1):50-8. PubMed ID: 10027088
[TBL] [Abstract][Full Text] [Related]
15. Comparative alpha-1 adrenoceptor subtype selectivity and functional uroselectivity of alpha-1 adrenoceptor antagonists.
Martin DJ; Lluel P; Guillot E; Coste A; Jammes D; Angel I
J Pharmacol Exp Ther; 1997 Jul; 282(1):228-35. PubMed ID: 9223558
[TBL] [Abstract][Full Text] [Related]
16. Studies on RX 781094: a selective, potent and specific antagonist of alpha 2-adrenoceptors.
Doxey JC; Roach AG; Smith CF
Br J Pharmacol; 1983 Mar; 78(3):489-505. PubMed ID: 6132640
[TBL] [Abstract][Full Text] [Related]
17. In vivo study on the effects of alpha1-adrenoceptor antagonists on intraurethral pressure in the prostatic urethra and intraluminal pressure in the vas deferens in male dogs.
Noguchi Y; Ohtake A; Suzuki M; Sasamata M
Eur J Pharmacol; 2008 Feb; 580(1-2):256-61. PubMed ID: 18078926
[TBL] [Abstract][Full Text] [Related]
18. (-)-Discretamine, a selective alpha 1D-adrenoceptor antagonist, isolated from Fissistigma glaucescens.
Ko FN; Guh JH; Yu SM; Hou YS; Wu YC; Teng CM
Br J Pharmacol; 1994 Aug; 112(4):1174-80. PubMed ID: 7952879
[TBL] [Abstract][Full Text] [Related]
19. Investigation of alpha1-adrenoceptor subtypes mediating vasoconstriction in rabbit cutaneous resistance arteries.
Smith KM; Macmillan JB; McGrath JC
Br J Pharmacol; 1997 Nov; 122(5):825-32. PubMed ID: 9384497
[TBL] [Abstract][Full Text] [Related]
20. The relationship between density of alpha-adrenoceptor binding sites and contractile responses in several porcine isolated blood vessels.
Wright IK; Blaylock NA; Kendall DA; Wilson VG
Br J Pharmacol; 1995 Feb; 114(3):678-88. PubMed ID: 7735695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
